Digitalni repozitorij raziskovalnih organizacij Slovenije

Izpis gradiva
A+ | A- | SLO | ENG

Naslov:Detection of EGFR variants in plasma : a multilaboratory comparison of a real-time PCR EGFR mutation test in Europe
Avtorji:Keppens, Cleo (Avtor)
Palma, John (Avtor)
Das, Partha (Avtor)
Scudder, Sidney (Avtor)
Wen, Wei (Avtor)
Normanno, Nicola (Avtor)
van Krieken, Han J. J. M. (Avtor)
Sacco, Alessandra (Avtor)
Fenizia, Francesca (Avtor)
Gonzalez de Castro, David (Avtor)
Hönigschnabl, Selma (Avtor)
Kern, Izidor (Avtor)
Lopez-Rios, Fernando (Avtor)
Lozano, Maria D. (Avtor)
Marchetti, Antonio (Avtor)
Halfon, Philippe (Avtor)
Schuuring, Ed (Avtor)
Setinek, Ulrike (Avtor)
Sorensen, Boe (Avtor)
Taniere, Phillipe (Avtor)
Tiemann, Markus (Avtor)
Vosmikova, Hana (Avtor)
Dequeker, Elisabeth (Avtor)
Jezik:Angleški jezik
Tipologija:1.01 - Izvirni znanstveni članek
Organizacija:Logo UKPBAG - Univerzitetna klinika za pljučne bolezni in alergijo Golnik
Povzetek:Molecular testing of EGFR is required to predict the response likelihood to targeted therapy in non-small cell lung cancer. Analysis of circulating tumor DNA in plasma may complement limitations of tumor tissue. This study evaluated the interlaboratory performance and reproducibility of a real-time PCR EGFR mutation test (cobas EGFR Mutation Test v2) to detect EGFR variants in plasma. Fourteen laboratories received two identical panels of 27 single-blinded plasma samples. Samples were wild type or spiked with plasmid DNA to contain seven common EGFR variants at six predefined concentrations from 50 to 5000 copies per milliliter. The circulating tumor DNA was extracted by a cell-free circulating DNA sample preparation kit (cobas cfDNA Sample Preparation Kit), followed by duplicate analysis with the real-time PCR EGFR mutation test (Roche Molecular Systems, Pleasanton, CA). Lowest sensitivities were obtained for the c.2156G>C p.(Gly719Ala) and c.2573T>G p.(Leu858Arg) variants for the lowest target copies. For all other variants, sensitivities varied between 96.3% and 100.0%. All specificities were 98.8% to 100.0%. Coefficients of variation indicated good intralaboratory and interlaboratory repeatability and reproducibility but increased for decreasing concentrations. Prediction models revealed a significant correlation for all variants between the predefined copy number and the observed semiquantitative index values, which reflect the samples' plasma mutation load. This study demonstrates an overall robust performance of the real-time PCR EGFR mutation test kit in plasma. Prediction models may be applied to estimate the plasma mutation load for diagnostic or research purposes.
Ključne besede:non-small cell lung cancer, plasma, EGFR, molecular testing
Leto izida:2018
Založnik:Elsevier
Izvor:ZDA
UDK:616-006
ISSN pri članku:1943-7811
OceCobissID:3615508 Povezava se odpre v novem oknu
COBISS_ID:2048314481 Povezava se odpre v novem oknu
DOI:10.1016/j.jmoldx.2018.03.006 Povezava se odpre v novem oknu
Opombe:Soavtorji: John F. Palma, Partha M. Das, Sidney Scudder, Wei Wen, Nicola Normanno, J. Han van Krieken, Alessandra Sacco, Francesca Fenizia, David Gonzalez de Castro, Selma Hönigschnabl, Izidor Kern, Fernando Lopez-Rios, Maria D. Lozano, Antonio Marchetti, Philippe Halfon, Ed Schuuring, Ulrike Setinek, Boe Sorensen, Phillipe Taniere, Markus Tiemann, Hana Vosmikova, and Elisabeth M.C. Dequeker; Nasl. z nasl. zaslona; Opis vira z dne 9. 7. 2018;
Število ogledov:721
Število prenosov:100
Datoteke:URL URL - Izvorni URL, za dostop obiščite https://jmd.amjpathol.org/article/S1525-1578(17)30514-7/fulltext
 
Nadgradivo:J. mol. diagn.
American Society for Investigative Pathology and the Association for Molecular Pathology
 
Metapodatki:XML RDF-CHPDL DC-XML DC-RDF
Avtorske pravice:2018 American Society for Investigative Pathology and the Association for Molecular Pathology
:
  
Postavite miškin kazalec na naslov za izpis povzetka. Klik na naslov izpiše podrobnosti ali sproži prenos.


Nazaj